Literature DB >> 9335515

The development of docetaxel (Taxotere) in non-small cell lung cancer.

M G Kris1, V A Miller, K K Ng, S C Grant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9335515

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  2 in total

1.  Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer.

Authors:  M I Koukourakis; A Giatromanolaki; S Kakolyris; M Froudarakis; V Georgoulias; G Retalis; N Bahlitzanakis
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

Review 2.  [Docetaxel (taxotere): current status of clinical development in non-small-cell bronchial carcinoma (NSCLC)].

Authors:  C Manegold
Journal:  Med Klin (Munich)       Date:  1998-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.